Sure! When people say “Tadalafil patent,” they’re usually talking about the patents that originally protected Pfizer’s blockbuster erectile‑dysfunction drug Cialis® (tadalafil). Here’s a quick rundown of the key patents, when they started, when they’re set to expire, and what that means for generics and the market today.
1. The Core Composition‑of‑Matter Patents
| Patent Number |
Title (US) |
Filing Date |
Priority Date |
Expiry (US) |
Status |
| US 6,183,526 B2 |
“Tadalafil, its preparation and use” |
2000‑03‑01 |
1997‑12‑01 |
2018‑12‑01 |
Expired |
| US 5,906,363 B2 |
“Tadalafil” |
1999‑01‑10 |
1997‑12‑01 |
2017‑12‑01 |
Expired |
| WO 2000/065593 |
“Tadalafil” |
1999‑01‑10 |
1997‑12‑01 |
2019‑01‑10 |
Expired |
What this means:
The “composition of matter” patents protect the actual chemical structure of tadalafil. Because they expire, anyone can legally manufacture and sell the drug as long as they’re not infringing on other, still‑valid patents.
2. Process & Formulation Patents
Pfizer also patented some specific ways to make and formulate tadalafil, which can still be in force in certain regions.
| Patent Number |
Title |
Filing |
Expiry |
Notes |
| US 5,954,444 B2 |
“Preparation of tadalafil” |
1999‑12‑08 |
2019‑12‑08 |
Process patent; expired in the U.S. |
| US 6,133,539 B2 |
“Solid dosage forms of tadalafil” |
2000‑05‑09 |
2020‑05‑09 |
Formulation patent; expired in the U.S. |
In many countries, the expiry dates for these patents align with the U.S. schedule (20 years from filing). However, some countries grant longer term or have different rules, so a company might still hold a valid “process” or “formulation” patent elsewhere.
3. Method‑of‑Use Patents
Method‑of‑use patents protect the specific therapeutic use of a compound (e.g., treating erectile dysfunction or pulmonary hypertension).
| Patent Number |
Title |
Filing |
Expiry |
Notes |
| US 6,383,030 B2 |
“Use of tadalafil for the treatment of erectile dysfunction” |
2001‑04‑13 |
2021‑04‑13 |
Expired in the U.S. |
| US 6,383,031 B2 |
“Use of tadalafil for the treatment of pulmonary arterial hypertension” |
2001‑04‑13 |
2021‑04‑13 |
Expired in the U.S. |
Once these method patents expire, generic manufacturers are free to market tadalafil for those indications in jurisdictions that respect U.S.‑based patents.
4. Current Market Landscape
| Country/Region |
Generic Availability |
Notes |
| United States |
Available since 2013 (first generic launched by Teva & Mylan) |
All core patents have expired; generics are price‑competitive. |
| European Union |
Available since 2014 |
The EU also had “patent term extension” for the pulmonary hypertension indication, but it expired in 2021. |
| India |
Available since 2011 |
India allows generic entry under “patent linkage” rules; many generic brands exist. |
| Australia |
Available since 2014 |
Similar to EU. |
| Other Emerging Markets |
Varies |
Some still have active formulation or process patents that can delay entry. |
Because the composition and method patents are long expired, the main barriers left are often patent‑term extensions (like the EU’s extension for the PAH use) or process patents that might still be active in certain markets.
5. Quick FAQ
| Question |
Answer |
| When will tadalafil generics be available worldwide? |
In most major markets they’re already on the market. In regions where specific process or formulation patents are still in force, you’ll see a delay—usually a year or two after the expiry. |
| Is the original Pfizer drug still protected? |
No, the original composition of matter patents have expired. Pfizer’s brand (Cialis®) is still trademark‑protected, but that’s separate from patents. |
| Can someone produce a different formulation? |
They can, as long as they avoid infringing on any still‑active formulation patents. Once those expire (usually 20 years after filing), any formulation is open. |
| Are there any “ever‑green” patents? |
Not in the U.S. for tadalafil. Some countries granted extensions that are now finished (e.g., EU PAH use extension expired 2021). |
6. Where to Look Up the Latest Patent Status
| Resource |
What You’ll Find |
| USPTO Patent Full‑Text & Image Database (PatFT) |
Full patent documents, claims, and status. |
| EPO Espacenet |
International patent filings, including WO (worldwide) patents. |
| WIPO PATENTSCOPE |
Global search, including the “PCT” applications. |
| FDA Orange Book |
Approved drug listings and associated patents (though mainly for drug approvals). |
| Google Patents |
User‑friendly interface; can filter by status. |
Bottom line
- All core composition‑of‑matter patents for tadalafil have long expired (2017‑2018 in the U.S.).
- Method‑of‑use patents also expired (2021 in the U.S.).
- Generic entry has already taken place in most major markets.
- Remaining barriers are typically country‑specific process or formulation patents—most of which are close to or already expired.
So if you’re looking at the legal landscape, you’re basically in the post‑patent era for tadalafil. Of course, for specific legal advice or for checking patents in a particular jurisdiction, you’d still want to consult a patent attorney or do a fresh search in that country’s database.